[HTML][HTML] Progesterone–friend or foe?

I Sundström-Poromaa, E Comasco, R Sumner… - Frontiers in …, 2020 - Elsevier
Estradiol is the “prototypic” sex hormone of women. Yet, women have another sex hormone,
which is often disregarded: Progesterone. The goal of this article is to provide a …

Premenstrual disorders

KA Yonkers, MK Simoni - American journal of obstetrics and gynecology, 2018 - Elsevier
Premenstrual disorders include premenstrual syndrome, premenstrual dysphoric disorder,
and premenstrual worsening of another medical condition. While the underlying causes of …

[HTML][HTML] Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids …

L Hantsoo, CN Epperson - Neurobiology of Stress, 2020 - Elsevier
Premenstrual dysphoric disorder (PMDD) is a severe mood disorder with core symptoms
(affective lability, irritability, depressed mood, anxiety) and increased sensitivity to stress …

Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA

L Hantsoo, JL Payne - Neuroscience & Biobehavioral Reviews, 2023 - Elsevier
Premenstrual dysphoric disorder (PMDD) is a severe mood disorder, with affective
symptoms that rise and fall in concert with the hormonal fluctuations of the menstrual cycle …

Management of premenstrual dysphoric disorder: a scoping review

SV Carlini, T Lanza di Scalea, ST McNally… - … Journal of Women's …, 2022 - Taylor & Francis
Premenstrual dysphoric disorder (PMDD) and premenstrual syndrome (PMS) refer to
physical, cognitive, or affective symptoms that arise in the late luteal phase and remit with …

[HTML][HTML] New pharmacological approaches to the management of premenstrual dysphoric disorder

I Sundström-Poromaa, E Comasco - CNS drugs, 2023 - Springer
Premenstrual symptoms are experienced by many female individuals during their fertile age.
Premenstrual dysphoric disorder (PMDD), a sex-specific mood disorder, affects about 5% of …

Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives

AJ Rapkin, Y Korotkaya, KC Taylor - Open Access Journal of …, 2019 - Taylor & Francis
Abstract Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual
syndrome (PMS) affecting up to 7% of reproductive age women. Women with PMDD are of …

GABA-ergic modulators: new therapeutic approaches to premenstrual dysphoric disorder

C Sikes-Keilp, DR Rubinow - CNS drugs, 2023 - Springer
Premenstrual dysphoric disorder (PMDD) is characterized by the predictable onset of mood
and physical symptoms secondary to gonadal steroid fluctuation during the luteal phase of …

[HTML][HTML] Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: toward precise targets …

Q Gao, W Sun, YR Wang, ZF Li, F Zhao… - Frontiers in …, 2023 - frontiersin.org
Premenstrual dysphoric disorder (PMDD) can be conceptualized as a disorder of suboptimal
sensitivity to neuroactive steroid hormones. Its core symptoms (emotional instability …

GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder

KN Miller, L Standeven, AL Morrow, JL Payne… - …, 2024 - Elsevier
Rationale Premenstrual dysphoric disorder (PMDD) affects approximately 5% of
menstruating individuals, with significant negative mood symptoms in the luteal phase of the …